Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Kirit Singh, Kelly M. Hotchkiss, Ian F. Parney, John De Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y. Wen, Giuseppe Minniti, Howard Colman, Timothy F. Cloughesy, Minesh P. Mehta, Marjolein Geurts, Isabel Arrillaga-Romany, Annick Desjardins, Kirk Tanner, Susan Short, David Arons, Elizabeth Duke, Wolfgang Wick, Stephen J. Bagley, David M. Ashley, Priya Kumthekar, Roel Verhaak, Anthony J. Chalmers, Anoop P. Patel, Colin Watts, Peter E. Fecci, Tracy T. Batchelor, Michael Weller, Michael A. Vogelbaum, Matthias Preusser, Mitchel S. Berger, Mustafa Khasraw

Open source

DOI: 10.1038/s41591-023-02464-8
Published: 2023-07-24
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-023-02464-8,
  title = {Correcting the drug development paradigm for glioblastoma requires serial tissue sampling},
  author = {Kirit Singh and Kelly M. Hotchkiss and Ian F. Parney and John De Groot and Solmaz Sahebjam and Nader Sanai and Michael Platten and Evanthia Galanis and Michael Lim and Patrick Y. Wen and Giuseppe Minniti and Howard Colman and Timothy F. Cloughesy and Minesh P. Mehta and Marjolein Geurts and Isabel Arrillaga-Romany and Annick Desjardins and Kirk Tanner and Susan Short and David Arons and Elizabeth Duke and Wolfgang Wick and Stephen J. Bagley and David M. Ashley and Priya Kumthekar and Roel Verhaak and Anthony J. Chalmers and Anoop P. Patel and Colin Watts and Peter E. Fecci and Tracy T. Batchelor and Michael Weller and Michael A. Vogelbaum and Matthias Preusser and Mitchel S. Berger and Mustafa Khasraw},
  year = {2023},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-023-02464-8},
  url = {https://doi.org/10.1038/s41591-023-02464-8}
}

RIS

TY  - JOUR
TI  - Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
AU  - Kirit Singh
AU  - Kelly M. Hotchkiss
AU  - Ian F. Parney
AU  - John De Groot
AU  - Solmaz Sahebjam
AU  - Nader Sanai
AU  - Michael Platten
AU  - Evanthia Galanis
AU  - Michael Lim
AU  - Patrick Y. Wen
AU  - Giuseppe Minniti
AU  - Howard Colman
AU  - Timothy F. Cloughesy
AU  - Minesh P. Mehta
AU  - Marjolein Geurts
AU  - Isabel Arrillaga-Romany
AU  - Annick Desjardins
AU  - Kirk Tanner
AU  - Susan Short
AU  - David Arons
AU  - Elizabeth Duke
AU  - Wolfgang Wick
AU  - Stephen J. Bagley
AU  - David M. Ashley
AU  - Priya Kumthekar
AU  - Roel Verhaak
AU  - Anthony J. Chalmers
AU  - Anoop P. Patel
AU  - Colin Watts
AU  - Peter E. Fecci
AU  - Tracy T. Batchelor
AU  - Michael Weller
AU  - Michael A. Vogelbaum
AU  - Matthias Preusser
AU  - Mitchel S. Berger
AU  - Mustafa Khasraw
PY  - 2023
JO  - Nature Medicine
DO  - 10.1038/s41591-023-02464-8
UR  - https://doi.org/10.1038/s41591-023-02464-8
ER  -

APA

Singh, K., Hotchkiss, K. M., Parney, I. F., Groot, J. D., Sahebjam, S., Sanai, N., Platten, M., Galanis, E., Lim, M., Wen, P. Y., Minniti, G., Colman, H., Cloughesy, T. F., Mehta, M. P., Geurts, M., Arrillaga-Romany, I., Desjardins, A., Tanner, K., Short, S., Arons, D., Duke, E., Wick, W., Bagley, S. J., Ashley, D. M., Kumthekar, P., Verhaak, R., Chalmers, A. J., Patel, A. P., Watts, C., Fecci, P. E., Batchelor, T. T., Weller, M., Vogelbaum, M. A., Preusser, M., Berger, M. S., & Khasraw, M. (2023). Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nature Medicine. https://doi.org/10.1038/s41591-023-02464-8

Source records

crossref · retrieved 2026-09-27T05:01:10.490Z